• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4597081)   Today's Articles (5282)   Subscriber (49346)
Number Citation Analysis
26
Hong X, Min SN, Zhang YY, Lin YT, Wang F, Huang Y, Yu GY, Wu LL, Yang HY. TNF-α Suppresses Autophagic Flux in Acinar Cells in IgG4-Related Sialadenitis. J Dent Res 2019;98:1386-1396. [PMID: 31461632 DOI: 10.1177/0022034519871890] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]  Open
27
Vitolo U, Witzig T, Gascoyne R, Scott D, Zhang Q, Jurczak W, Özcan M, Hong X, Zhu J, Jin J, Belada D, Bergua J, Piazza F, Mócikova H, Molinari A, Yoon D, Cavallo F, Tani M, Izutsu K, Kato K, Czuczman M, Hersey S, Kilcoyne A, Russo J, Hudak K, Zhang J, Chiappella A, Nowakowski G. ROBUST: First report of phase III randomized study of lenalidomide/R-CHOP (R2 -CHOP) vs placebo/R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma. Hematol Oncol 2019. [DOI: 10.1002/hon.5_2629] [Citation(s) in RCA: 71] [Impact Index Per Article: 14.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
28
Leonard J, Trneny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Czuczman M, Kalambakas S, Fustier P, Wu C, Gribben J. AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R2 ) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY FOLLICULAR PATIENTS IRRESPECTIVE OF POD24 STATUS. Hematol Oncol 2019. [DOI: 10.1002/hon.75_2629] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
29
Thieblemont C, Leonard J, Trneny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Czuczman M, Kalambakas S, Fustier P, Wu C, Gribben J. POST HOC ANALYSES OF PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA WHO RECEIVED LENALIDOMIDE PLUS RITUXIMAB (R2 ) VS RITUXIMAB/PLACEBO (AUGMENT). Hematol Oncol 2019. [DOI: 10.1002/hon.41_2630] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
30
Leonard J, Trněny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Tabah A, Abouzaid S, Kalambakas S, Fustier P, Wu C, Gribben J. HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R2 ) VERSUS R PLUS PLACEBO. Hematol Oncol 2019. [DOI: 10.1002/hon.45_2630] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
31
Gribben J, Trneny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Czuczman M, Kalambakas S, Fustier P, Wu C, Leonard J. AUGMENT: RELAPSED/REFRACTORY INDOLENT NHL PATIENTS WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2 ) THAN RITUXIMAB/PLACEBO. Hematol Oncol 2019. [DOI: 10.1002/hon.42_2630] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
32
Gribben J, Trneny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Czuczman M, Kalambakas S, Fustier P, Wu C, Leonard J. PS1252 PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2) THAN RITUXIMAB/PLACEBO (AUGMENT). Hemasphere 2019. [DOI: 10.1097/01.hs9.0000563288.81673.b1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]  Open
33
Guan Z, Li Q, Zhang H, Shen P, Zheng L, Chu S, Park C, Hong X, Liu R, Wang P, Liu B, Shen G. Pressure induced transformation and subsequent amorphization of monoclinic Nb2O5 and its effect on optical properties. JOURNAL OF PHYSICS. CONDENSED MATTER : AN INSTITUTE OF PHYSICS JOURNAL 2019;31:105401. [PMID: 30566910 DOI: 10.1088/1361-648x/aaf9bd] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
34
Yu GY, Hong X, Li W, Zhang YY, Gao Y, Chen Y, Zhang ZY, Xie XY, Li ZG, Liu YY, Su JZ, Zhu WX, Sun ZP. [Clinicopathological characteristics and diagnosis of IgG4related sialadenitis]. JOURNAL OF PEKING UNIVERSITY. HEALTH SCIENCES 2019;51:1-3. [PMID: 30773535 DOI: 10.19723/j.issn.1671-167x.2019.01.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
35
Zheng F, Tang D, Xu H, Xu Y, Dai W, Zhang X, Hong X, Liu D, Dai Y. Genomewide analysis of 6-methyladenine DNA in peripheral blood mononuclear cells of systemic lupus erythematosus. Lupus 2019;28:359-364. [PMID: 30744524 DOI: 10.1177/0961203319828520] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
36
Hong X, Bao CS, Zheng WL. Inference on Injury Mechanism of Ankle Fracture by Lauge-Hansen Classification. FA YI XUE ZA ZHI 2018;34:512-515. [PMID: 30468054 DOI: 10.12116/j.issn.1004-5619.2018.05.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 07/16/2018] [Indexed: 11/30/2022]
37
Song Y, Hong X, Huang H, Bai B, Zhang H, Ke X, Shi Y, Zhu J, Lu G, Liebscher S, Cai C. Safety and efficacy of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma from China. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy437.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
38
Shi Y, Zhang Q, Han X, Song Y, Qin Y, Hong X, Ke X, Feng J, Wang D, Li W, Su H, Zhang Y, Zhang H, Yang J, Liu L, Zhang X, Liu E, Jiang W, Liu S, Luk A. First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy437.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
39
Toh Z, Gu Q, Seah T, Wong W, McNab J, Chuang K, Hong X, Tang P. Increased white matter connectivity seen in young judo athletes with MRI. Clin Radiol 2018. [DOI: 10.1016/j.crad.2018.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
40
Zhang J, Ding Y, Chen CC, Cai Z, Chang J, Chen B, Hong X, Fluerasu A, Zhang Y, Ku CS, Brewe D, Heald S, Ishii H, Hiraoka N, Tsuei KD, Liu W, Zhang Z, Cai YQ, Gu G, Irifune T, Mao HK. Evolution of a Novel Ribbon Phase in Optimally Doped Bi2Sr2CaCu2O8+δ at High Pressure and Its Implication to High- TC Superconductivity. J Phys Chem Lett 2018;9:4182-4188. [PMID: 29979596 DOI: 10.1021/acs.jpclett.8b01849] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
41
Ying Y, Hong X, Xu X, Ma K, He J, Zhu F. A novel mutation +5904 C>T of RUNX1 site in the erythroid cell-specific regulatory element decreases the ABO antigen expression in Chinese population. Vox Sang 2018;113:594-600. [PMID: 29978484 DOI: 10.1111/vox.12676] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2018] [Revised: 04/16/2018] [Accepted: 06/10/2018] [Indexed: 12/11/2022]
42
Lloyd CE, Nouwen A, Sartorius N, Ahmed HU, Alvarez A, Bahendeka S, Basangwa D, Bobrov AE, Boden S, Bulgari V, Burti L, Chaturvedi SK, Cimino LC, Gaebel W, de Girolamo G, Gondek TM, de Braude MG, Guntupalli A, Heinze MG, Ji L, Hong X, Khan A, Kiejna A, Kokoszka A, Kamala T, Lalic NM, Lecic Tosevski D, Mankovsky B, Li M, Musau A, Müssig K, Ndetei D, Rabbani G, Srikanta SS, Starostina EG, Shevchuk M, Taj R, Vukovic O, Wölwer W, Xin Y. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabet Med 2018;35:760-769. [PMID: 29478265 DOI: 10.1111/dme.13611] [Citation(s) in RCA: 69] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/21/2018] [Indexed: 01/23/2023]
43
Hong X, Yu H, Wang B. [Progress on influencing factors regarding the neonatal group B streptococcal infectious diseases]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2018;39:249-252. [PMID: 29495215 DOI: 10.3760/cma.j.issn.0254-6450.2018.02.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
44
Yao Z, Qin Z, Lin P, Hong X, Wang L, Dai Y, Yao X. Case study of Allii Macrostemonis Bulbus: From chemical and metabolic profile to quality control by UPLC/Q-TOF-MS. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
45
Escolar ML, Kiely BT, Shawgo E, Hong X, Gelb MH, Orsini JJ, Matern D, Poe MD. Psychosine, a marker of Krabbe phenotype and treatment effect. Mol Genet Metab 2017;121:271-278. [PMID: 28579020 PMCID: PMC5548593 DOI: 10.1016/j.ymgme.2017.05.015] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Revised: 05/21/2017] [Accepted: 05/21/2017] [Indexed: 10/19/2022]
46
Feng B, Lu J, Zhang S, Yan X, Li J, Xue P, Wang M, Lu A, Ma J, Zang L, Dong F, He Z, Yue F, Sun J, Hong X, Zheng M. Laparoscopic abdominoperineal excision with trans-abdominal individualized levator transection: interim analysis of a randomized controlled trial. Colorectal Dis 2017;19:O246-O252. [PMID: 28477432 DOI: 10.1111/codi.13711] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2016] [Accepted: 02/24/2017] [Indexed: 02/08/2023]
47
Kostakoglu L, Martelli M, Belada D, Carella A, Chua N, Gonzalez-Barca E, Hong X, Pinto A, Sehn L, Shi Y, Tatsumi Y, Fingerle-Rowson G, Mattiello F, Nielsen T, Sahin D, Vitolo U, Trněný M. END OF TREATMENT PET-CT PREDICTS PROGRESSION-FREE SURVIVAL IN DLBCL AFTER FIRST-LINE TREATMENT: RESULTS FROM THE PHASE III GOYA STUDY. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_45] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
48
Xia Z, Lv F, Xue K, Zhang Q, Ji D, Cao J, Hong X, Guo Y. PEGYLATED LIPOSOMAL DOXORUBICIN COMBINED WITH CYCLOPHOSPHAMIDE, VINCRISTINE/VINDESINE, AND PREDNISONE IN PATIENTS WITH AGGRESSIVE T-CELL LYMPHOMA: PRELIMINARY RESULTS OF APHASE II STUDY. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
49
Li C, Ma X, Pan Z, Lv F, Xia Z, Xue K, Zhang Q, Ji D, Cao J, Hong X, Guo Y. Consolidation radiotherapy does not improve the outcome as compared with chemotherapy alone in patients with limited stage diffuse large B-cell lymphoma of Waldeyer's ring. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_76] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
50
Lv F, Xia Z, Xue K, Zhang Q, Ji D, Cao J, Hong X, Guo Y. Preliminary results of a phase II study using response-adapted therapy for limited-stage diffuse large B-cell lymphoma based on interim PET/CT. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
PrevPage 2 of 10 12345910Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA